FE
64
-2
QCOM
64
6
KIM
66
8
L
49
-9
GME
89
2
PRU
57
7
OI
55
3
CA
34
-6
LYB
29
11
WMB
62
2
ES
42
-2
TSN
43
11
TGT
56
6
NSC
70
17
ADI
71
8
FAST
57
4
XYL
72
20
RHI
34
9
EMC
73
12
AIV
46
2
FE
64
-2
QCOM
64
6
KIM
66
8
L
49
-9
GME
89
2
PRU
57
7
OI
55
3
CA
34
-6
LYB
29
11
WMB
62
2
ES
42
-2
TSN
43
11
TGT
56
6
NSC
70
17
ADI
71
8
FAST
57
4
XYL
72
20
RHI
34
9
EMC
73
12
AIV
46
2
Financhill
Back

OncoCyte Stock Price Chart

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
31

OCX
OncoCyte

Last Price:
$2.70
Seasonality Move:
-17.89%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight selling pressure.

OncoCyte Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.91 Sell
20-day SMA: 2.99 Sell
50-day SMA: 3.18 Sell
200-day SMA: 2.84 Sell
8-day EMA: 2.9 Sell
20-day EMA: 2.97 Sell
50-day EMA: 2.97 Sell
200-day EMA: 2.92 Sell

OncoCyte Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 41.71 Sell
Chaikin Money Flow: -12281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.79 - 3.13) Sell
Bollinger Bands (100): (2.17 - 3.27) Buy

OncoCyte Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for OncoCyte Stock

Is OncoCyte Stock a Buy?

  • OncoCyte share price is 2.81 while OCX 8-day simple moving average is 2.91, which is a Sell signal.
  • The stock price of OCX is 2.81 while OncoCyte 20-day SMA is 2.99, which makes it a Sell.
  • OncoCyte 50-day simple moving average is 3.18 while OCX share price is 2.81, making it a Sell technically.
  • OCX stock price is 2.81 and OncoCyte 200-day simple moving average is 2.84, creating a Sell signal.

OCX Technical Analysis vs Fundamental Analysis

Sell
31
OncoCyte (OCX) is a Sell

Is OncoCyte a Buy or a Sell?

  • OncoCyte stock is rated a Sell
    The current OncoCyte [OCX] share price is $2.81. The Score for OCX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.

OncoCyte Stock Info

Market Cap:
80.4M
Price in USD:
2.81
Share Volume:
64.5K

OncoCyte 52-Week Range

52-Week High:
4.75
52-Week Low:
1.92
Sell
31
OncoCyte (OCX) is a Sell

OncoCyte Share Price Forecast

  • What is the OncoCyte stock price today?
    The OncoCyte stock price is 2.81 USD today.
  • Will OCX stock go up or go down?
    OncoCyte> share price is forecast to RISE/FALL based on technical indicators
  • Is OncoCyte overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, OncoCyte is overvalued.

Is OncoCyte Stock a Buy?

  • OncoCyte share price is 2.81 while OCX 8-day exponential moving average is 2.90, which is a Sell signal.
  • The stock price of OCX is 2.81 while OncoCyte 20-day EMA is 2.97, which makes it a Sell.
  • OncoCyte 50-day exponential moving average is 2.97 while OCX share price is 2.81, making it a Sell technically.
  • OCX stock price is 2.81 and OncoCyte 200-day simple moving average is 2.92, creating a Sell signal.

Fundamental Analysis of OncoCyte

Is OncoCyte a good investment?

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.04 per share.

Technical Analysis of OncoCyte

Should I short OncoCyte stock?

  • OCX Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting OncoCyte is a Sell
  • OncoCyte Relative Strength Index (RSI) is 41.71, which suggest OncoCyte is oversold
  • The Bollinger Bands (25) for OncoCyte is (2.79 - 3.13), which suggest OncoCyte is a Buy
  • The Bollinger Bands (100) for OncoCyte is (2.17 - 3.27), which suggest OncoCyte is a Buy

* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.